Arca
Skip to content
Tools
Tools

Neuroendocrine cancer

Drug research and approvals for neuroendocrine cancer: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 22, 2026, 706 studies of neuroendocrine cancer are recruiting on ClinicalTrials.gov, and Health Canada has authorized 0 drug trials for it since 2013.

  • Recruiting worldwide: 706
  • Trials authorized in Canada: 0
  • FDA orphan approvals: 0
  • EU medicines: 0

Recruiting now

Newest posted first, of 706 recruiting on ClinicalTrials.gov ↗

Drug pipeline

Each drug at the furthest stage it has reached for this condition or a subtype of it, from ChEMBL's drug indications

Approved 5

  • AvelumabMerkel cell cancer · Programmed cell death 1 ligand 1 other
  • VandetanibMedullary cancer · Tyrosine-protein kinase SRC inhibitor
  • RetifanlimabMerkel cell cancer · Programmed cell death protein 1 antagonist
  • SelpercatinibMedullary cancer · Tyrosine-protein kinase receptor RET inhibitor
  • PralsetinibMedullary cancer · Tyrosine-protein kinase receptor RET inhibitor

Phase 3 7

Phase 2 12 of 55

Phase 1 or earlier 12 of 14

How its trials ended

262 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrong

Of the 49 whose ending is known, 31% met their primary endpoint, 12% missed it and 57% stopped early.

  • Ongoing11142%
  • Completed, result not reported6926%
  • Status unknown3313%
  • Stopped: other or unclear176%
  • Met its primary endpoint156%
  • Missed its primary endpoint62%
  • Stopped: enrollment or feasibility62%
  • Stopped: sponsor or business decision31%
  • Stopped: lack of efficacy1<1%
  • Stopped: funding1<1%

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.